Search Knowledge Base

29 results for "maltose"

Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review pubmed_article
Evidence Source 2025 PMID: 39935027
Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials pubmed_article
Evidence Source 2025 PMID: 40091548
Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports pubmed_article
Evidence Source 2025 PMID: 40402208
A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy pubmed_article
Evidence Source 2024 PMID: 38765534
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial pubmed_article
Evidence Source 2024 PMID: 39185895
Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis pubmed_article
Evidence Source 2020 PMID: 33586856
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial pubmed_article
Evidence Source 2025 PMID: 40159390
Effect of IV ferric carboxy maltose for moderate/severe anemia: a systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 38405188
Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 38439125
Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 39839869
Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial pubmed_article
Evidence Source 2023 PMID: 36107229
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose pubmed_article
Evidence Source 2023 PMID: 37010731
Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis pubmed_article
Evidence Source 2023 PMID: 37632415
Ferric Carboxymaltose in Heart Failure with Iron Deficiency pubmed_article
Evidence Source 2023 PMID: 37632463
A Systematic Review, Meta-Analysis, and Indirect Comparison of Blindly Adjudicated Cardiovascular Event Incidence with Ferric Derisomaltose, Ferric Carboxymaltose, and Iron Sucrose pubmed_article
Evidence Source 2022 PMID: 35947351
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial pubmed_article
Evidence Source 2022 PMID: 36347265
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis pubmed_article
Evidence Source 2021 PMID: 33188534
Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis pubmed_article
Evidence Source 2021 PMID: 34011020
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials pubmed_article
Evidence Source 2020 PMID: 32016310
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial pubmed_article
Evidence Source 2020 PMID: 33197395
A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment pubmed_article
Evidence Source 2019 PMID: 30689458
Ferric carboxymaltose in patients with heart failure and iron deficiency pubmed_article
Evidence Source 2009 PMID: 19920054
Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo. unknown
wiki/source/pmid-35532871
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial. unknown
wiki/source/pmid-39938943
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes. unknown
wiki/source/pmid-40740027
Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia unknown
wiki/sources/nct-nct06948864
Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo. unknown
wiki/sources/pmid-35532871
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial. unknown
wiki/sources/pmid-39938943
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes. unknown
wiki/sources/pmid-40740027

Evidence Search Results semantic · quality-ranked

Effect of IV ferric carboxy maltose for moderate/severe anemia: a systematic review and meta-analysis systematic_review pubmed_article
Quality: 67 2024 PMID: 38405188 DOI: 10.3389/fmed.2024.1340158
Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials meta_analysis pubmed_article
Quality: 66 2025 PMID: 40091548 DOI: 10.4274/tjh.galenos.2025.2025.0034
**Tanrıverdi et al., 2025** | Turk J Haematol | Meta Analysis Tanrıverdi Lokman Hekim, Sarıcı Ahmet. Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Ane...
A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy meta_analysis pubmed_article
Quality: 63 2024 PMID: 38765534 DOI: 10.61622/rbgo/2024AO21
**Gupte et al., 2024** | Rev Bras Ginecol Obstet | Meta Analysis Gupte Sanjay, Mukhopadhyay Ashis, ... Swami Onkar C. A meta-analysis of ferric carboxymaltose versus other intravenous iron preparation...
Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis meta_analysis pubmed_article
Quality: 61 2020 PMID: 33586856 DOI: 10.1002/ehf2.13146
**Khan et al., 2020** | ESC Heart Fail | Meta Analysis Khan Muhammad Shahzeb, Usman Muhammad Shariq, ... Stewart Coats Andrew J. Ferric carboxymaltose for the treatment of iron-deficient heart failure...
Intake or Blood Levels of Magnesium and Risk of Metabolic Syndrome: A Meta-Analysis of Observational Studies meta_analysis pubmed_article
Quality: 73 2025 PMID: 40431407 DOI: 10.3390/nu17101667
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review systematic_review pubmed_article
Quality: 51 2025 PMID: 39935027 DOI: 10.1002/ajh.27598
**Magagnoli et al., 2025** | Am J Hematol | Systematic Review Magagnoli Joseph, Knopf Kevin, ... Bennett Charles L. Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review. ...
Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports systematic_review pubmed_article
Quality: 50 2025 PMID: 40402208 DOI: 10.1007/s00228-025-03849-z
**Galigutta et al., 2025** | Eur J Clin Pharmacol | Systematic Review Galigutta Reddikumar Reddy, Thomas Christy, ... Undela Krishna. Signal detection of ferric carboxymaltose-induced serious adverse ...
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial rct pubmed_article
Quality: 61 2024 PMID: 39185895 DOI: 10.1093/eurheartj/ehae479
BACKGROUND AND AIMS: Evidence is lacking that correcting iron deficiency (ID) has clinically important benefits for patients with heart failure with preserved ejection fraction (HFpEF). METHODS: FAIR-...
Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review systematic_review pubmed_article
Quality: 59 2024 PMID: 38245797 DOI: 10.1186/s13023-024-03021-3
Laxatives or methylnaltrexone for the management of constipation in palliative care patients meta_analysis pubmed_article
Quality: 71 2011 PMID: 21249653 DOI: 10.1002/14651858.CD003448.pub3

View full evidence search →